Subscribe To
VAXX / Why Did Vaxxinity (VAXX) Stock Gain 80% Today?
VAXX News
By Zacks Investment Research
September 7, 2023
Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX)
The heavy selling pressure might have exhausted for Vaxxinity, Inc. (VAXX) as it is technically in oversold territory now. In addition to this technic more_horizontal
By The Motley Fool
January 19, 2023
Why Shares of Vaxxinity Jumped This Week
Investors are hoping the company's COVID-19 vaccine will turn the company from a clinical-stage biotech to a commercial one. more_horizontal
By Seeking Alpha
January 17, 2023
Vaxxinity: Potential Strong Upsides Ahead
We may not be at the end credits for COVID-19 virus. Shares of Vaxxinity, Inc., like most biotechs, have plummeted over the past year due to unprecede more_horizontal
By The Motley Fool
December 2, 2022
Why Shares of Vaxxinity Soared This Week
Positive news regarding a different company's Alzheimer's treatment may have helped Vaxxinity. more_horizontal
By InvestorPlace
April 29, 2022
Why Did Vaxxinity (VAXX) Stock Gain 80% Today?
VAXX stock gained more than 80% on Friday after Vaxxinity announced it has enrolled patients for the next part of its trials. The post Why Did Vaxxini more_horizontal